Figure 2 | British Journal of Cancer

Figure 2

From: Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality

Figure 2

Breast cancer mortality rates predicted by MISCAN for effects of screening and adjuvant therapy (chemotherapy and tamoxifen). (A) Age group 45–54 (assumed first screening attendance rate of 79% in the age group 50–54). (B) Age group 55–64 (assumed first screening attendance rate of 76–79% in the age group 55–64). (C) Age group 65–74 (assumed first screening attendance rate of 72–74% in the age group 65–69).

Back to article page